Growth Metrics

Celularity (CELU) Net Income towards Common Stockholders (2020 - 2025)

Celularity (CELU) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$24.4 million as the latest value for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 83.49% year-over-year to -$24.4 million; the TTM value through Dec 2025 reached -$91.8 million, down 58.57%, while the annual FY2025 figure was -$91.8 million, 58.57% down from the prior year.
  • Net Income towards Common Stockholders hit -$24.4 million in Q4 2025 for Celularity, down from -$23.1 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $49.9 million in Q3 2021 and bottomed at -$93.9 million in Q3 2023.
  • Average Net Income towards Common Stockholders over 5 years is -$21.6 million, with a median of -$20.9 million recorded in 2024.
  • Year-over-year, Net Income towards Common Stockholders soared 704.8% in 2022 and then tumbled 2056.16% in 2023.
  • Celularity's Net Income towards Common Stockholders stood at -$4.0 million in 2021, then skyrocketed by 704.8% to $24.4 million in 2022, then plummeted by 60.93% to $9.5 million in 2023, then tumbled by 239.22% to -$13.3 million in 2024, then crashed by 83.49% to -$24.4 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$24.4 million, -$23.1 million, and -$24.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.